12
Participants
Start Date
April 30, 2016
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2020
Placebo
Placebo with capsules that look like the 11β-MNTDC capsules but with no active ingredients
11βmethyl nortestosterone dodecylcarbonate
Escalating doses of 100, 200, 400, and 800 mg 11β-MNTDC
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance
University of Washington, Seattle
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of Washington
OTHER
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER
Premier Research
OTHER